INTELLIGENT BIO SOLUTIONS INC. Accounts Receivable, Sale
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Accounts Receivable, Sale of $1.40 million for the 12-month period ending 2023-06-30, per its 10-K filed 2023-08-23.
Discontinued › Notes
us-gaap:AccountsReceivableSale · last filed 2023-08-23
- INTELLIGENT BIO SOLUTIONS INC. accounts receivable, sale for the quarter ending 2023-06-30 was $1.40M, a 600.00% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. accounts receivable, sale for the quarter ending 2023-03-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. accounts receivable, sale for the quarter ending 2022-12-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. accounts receivable, sale for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. accounts receivable, sale for fiscal 2023 was $1.40M, a 33.33% decline from fiscal 2022.
- INTELLIGENT BIO SOLUTIONS INC. accounts receivable, sale for fiscal 2022 was $2.10M.
| Period end | Accounts Receivable, Sale 3 month | Accounts Receivable, Sale 6 month | Accounts Receivable, Sale 9 month | Accounts Receivable, Sale 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $1.40M derived: sum of 2 quarters · filed 2023-08-23 | $1.40M derived: sum of 3 quarters · filed 2023-08-23 | $1.40M 10-K · filed 2023-08-23 |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $0.00 10-Q · filed 2023-05-11 | $200.00K derived: sum of 4 quarters · filed 2023-08-23 |
| 2022-12-31 | $0.00 10-Q · filed 2023-02-14 | $0.00 10-Q · filed 2023-02-14 | $200.00K derived: sum of 3 quarters · filed 2023-08-23 | $200.00K derived: sum of 4 quarters · filed 2023-08-23 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $200.00K derived: sum of 2 quarters · filed 2023-08-23 | $200.00K derived: sum of 3 quarters · filed 2023-08-23 | $200.00K derived: sum of 4 quarters · filed 2023-08-23 |
| 2022-06-30 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $200.00K derived: sum of 2 quarters · filed 2023-08-23 | $200.00K derived: sum of 3 quarters · filed 2023-08-23 | $2.10M 10-K · filed 2023-08-23 |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | $1.90M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | $1.90M 10-Q · filed 2022-02-11 | ||
| 2021-09-30 | $1.90M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |